MX2023006126A - Produccion de arn. - Google Patents

Produccion de arn.

Info

Publication number
MX2023006126A
MX2023006126A MX2023006126A MX2023006126A MX2023006126A MX 2023006126 A MX2023006126 A MX 2023006126A MX 2023006126 A MX2023006126 A MX 2023006126A MX 2023006126 A MX2023006126 A MX 2023006126A MX 2023006126 A MX2023006126 A MX 2023006126A
Authority
MX
Mexico
Prior art keywords
rna
rna manufacturing
manufacturing
dsrna
double
Prior art date
Application number
MX2023006126A
Other languages
English (en)
Spanish (es)
Inventor
Stephanie Fesser
Andreas Kuhn
Thomas Ziegenhals
Original Assignee
BioNTech SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BioNTech SE filed Critical BioNTech SE
Publication of MX2023006126A publication Critical patent/MX2023006126A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/30Nucleotides
    • C12P19/34Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y207/00Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07Nucleotidyltransferases (2.7.7)
    • C12Y207/07006DNA-directed RNA polymerase (2.7.7.6)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • A61K31/7115Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • C12N9/1247DNA-directed RNA polymerase (2.7.7.6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/50Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MX2023006126A 2020-12-09 2021-12-07 Produccion de arn. MX2023006126A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063123465P 2020-12-09 2020-12-09
US202063132473P 2020-12-30 2020-12-30
PCT/EP2021/084488 WO2022122689A1 (en) 2020-12-09 2021-12-07 Rna manufacturing

Publications (1)

Publication Number Publication Date
MX2023006126A true MX2023006126A (es) 2023-07-28

Family

ID=79287682

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023006126A MX2023006126A (es) 2020-12-09 2021-12-07 Produccion de arn.

Country Status (10)

Country Link
US (1) US20240110214A1 (enExample)
EP (1) EP4259161A1 (enExample)
JP (1) JP2023552468A (enExample)
KR (1) KR20230129432A (enExample)
AU (1) AU2021395736A1 (enExample)
CA (1) CA3201552A1 (enExample)
IL (1) IL303457A (enExample)
MX (1) MX2023006126A (enExample)
TW (1) TW202237844A (enExample)
WO (1) WO2022122689A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ310613B6 (cs) 2020-09-23 2026-01-28 Ústav organické chemie a biochemie AV ČR, v. v. i. Lipidoidy pro transfekci nukleových kyselin a jejich použití
AU2022282559A1 (en) * 2021-05-26 2024-01-04 Etherna Immunotherapies Nv Method to reduce double stranded rna by-product formation
CZ310443B6 (cs) 2021-07-19 2025-06-25 Ústav organické chemie a biochemie AV ČR, v. v. i. Cyklohexanové lipidoidy pro transfekci nukleových kyselin a jejich použití
WO2023025404A1 (en) 2021-08-24 2023-03-02 BioNTech SE In vitro transcription technologies
JP2026506504A (ja) * 2023-02-01 2026-02-25 ジェンスクリプト ユーエスエー インク インビトロ転写方法及びそのための化合物
WO2024232914A1 (en) * 2023-05-05 2024-11-14 Trilink Biotechnologies, Llc In vitro transcription method
WO2025170909A1 (en) * 2024-02-05 2025-08-14 The Broad Institute, Inc. Nucleic acids with region-specific modifications and methods of making the same
WO2025223684A1 (en) * 2024-04-23 2025-10-30 BioNTech SE Methods and compositions for stimulating immune response

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995008626A1 (en) 1993-09-20 1995-03-30 The Regents Of The University Of Colorado Strategy for the production of rna from immobilized templates
US7074596B2 (en) 2002-03-25 2006-07-11 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Synthesis and use of anti-reverse mRNA cap analogues
US8304529B2 (en) 2006-07-28 2012-11-06 Life Technologies Corporation Dinucleotide MRNA cap analogs
CN104072561B (zh) 2007-06-19 2017-12-22 路易斯安那州州立大学及农业机械学院管理委员会 信使rna帽的抗‑反向硫代磷酸类似物的合成和用途
PL215513B1 (pl) 2008-06-06 2013-12-31 Univ Warszawski Nowe boranofosforanowe analogi dinukleotydów, ich zastosowanie, czasteczka RNA, sposób otrzymywania RNA oraz sposób otrzymywania peptydów lub bialka
DE102008061522A1 (de) 2008-12-10 2010-06-17 Biontech Ag Verwendung von Flt3-Ligand zur Verstärkung von Immunreaktionen bei RNA-Immunisierung
EP2281579A1 (en) 2009-08-05 2011-02-09 BioNTech AG Vaccine composition comprising 5'-Cap modified RNA
EP2625189B1 (en) 2010-10-01 2018-06-27 ModernaTX, Inc. Engineered nucleic acids and methods of use thereof
WO2013059475A1 (en) 2011-10-18 2013-04-25 Life Technologies Corporation Alkynyl-derivatized cap analogs, preparation and uses thereof
EP3155129B1 (en) * 2014-06-10 2019-01-16 CureVac AG Method for enhancing rna production
WO2016005004A1 (en) 2014-07-11 2016-01-14 Biontech Rna Pharmaceuticals Gmbh Stabilization of poly(a) sequence encoding dna sequences
CN120842296A (zh) 2015-09-21 2025-10-28 垂林克生物技术有限公司 用于合成5’-加帽rna的组合物和方法
WO2017059902A1 (en) 2015-10-07 2017-04-13 Biontech Rna Pharmaceuticals Gmbh 3' utr sequences for stabilization of rna
CN116144626A (zh) 2016-01-13 2023-05-23 新英格兰生物实验室公司 T7 rna聚合酶的热稳定变体
US10337051B2 (en) * 2016-06-16 2019-07-02 The Regents Of The University Of California Methods and compositions for detecting a target RNA
US10960070B2 (en) 2016-10-25 2021-03-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Prefusion coronavirus spike proteins and their use

Also Published As

Publication number Publication date
US20240110214A1 (en) 2024-04-04
AU2021395736A1 (en) 2023-07-27
TW202237844A (zh) 2022-10-01
EP4259161A1 (en) 2023-10-18
AU2021395736A9 (en) 2024-05-16
JP2023552468A (ja) 2023-12-15
WO2022122689A1 (en) 2022-06-16
CA3201552A1 (en) 2022-06-16
KR20230129432A (ko) 2023-09-08
IL303457A (en) 2023-08-01

Similar Documents

Publication Publication Date Title
MX2023006126A (es) Produccion de arn.
PH12019501457A1 (en) Compositions and methods for treating alpha-1 antitrypsin deficiency
MX2022012296A (es) Proceso mediado por enzimas para la elaboracion de amberketal y homologos de amberketal.
WO2018146557A3 (en) Long double-stranded rna for rna interference
WO2019068011A3 (en) Genetic knockouts in wood-ljungdahl microorganisms
MY143994A (en) Aerated food products and methods for producing them
EP4529777A3 (en) Allulose syrups
MY193225A (en) Methods for continuous production of products from microorganisms
MX2023002960A (es) Tecnologia de proceso para fabricacion de productos biologicos y purificacion aguas abajo.
MX2022009658A (es) Composiciones y metodos para la edicion de genes de calicreina (klkb1).
MX2022010793A (es) Metodos para refinacion de licores fuertes.
MY204032A (en) Sugar reduced products and method of producing thereof
MX2020001755A (es) Productos de aleacion de aluminio que tienen microestructura recristalizada selectivamente y metodos para su fabricacion.
WO2019079656A8 (en) Selective enrichment of a population of dna in a mixed dna sample through targeted suppression of dna amplification
WO2021146654A8 (en) Silk coated leather and products and methods of preparing the same
WO2019071052A3 (en) Production of polyhydroxybutyrate in wood-ljungdahl microorganisms
WO2022266456A3 (en) Proteases for beer haze reduction
CA3019753C (en) Cell culture process
ZA202300501B (en) Method, computer system and computer program product for improved table processing
WO2022090801A3 (en) Pvrl2 and/or pvrig as biomarkers for treatment
ECSP24032712A (es) Composiciones y métodos para el tratamiento de la pérdida de audición asociada a kcnq4
MX2024003331A (es) Moleculas de union a d3 y usos de estas.
GB202216606D0 (en) Methods, uses and products
MX2019005149A (es) Arn bicatenario con modificaciones quimicas postranscripcionales.
WO2022149142A3 (en) Pluripotent stem cell aggregates and microtissues obtained therefrom for the cultured meat industry